NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Netflix
NFLX
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
AVDL Avadel Pharmaceuticals
- 10.520
- -0.015-0.14%
Trading Dec 30 13:54 ET
1.01BMarket Cap-14.03P/E (TTM)
10.670High10.300Low326.28KVolume10.510Open10.535Pre Close3.39MTurnover0.39%Turnover RatioLossP/E (Static)96.36MShares19.09052wk High13.57P/B891.91MFloat Cap9.41052wk Low--Dividend TTM84.78MShs Float43.600Historical High--Div YieldTTM3.51%Amplitude0.710Historical Low10.376Avg Price1Lot Size
About Avadel Pharmaceuticals Company
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAVDL
Company NameAvadel Pharmaceuticals
Listing DateJun 6, 1996
Issue Price10.39
Founded2015
CEOMr. Gregory J. Divis
MarketNASDAQ
Employees154
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code02
Phone353-1-901-5201
Websitehttp://www.avadel.com
Company Executives
- Name
- Position
- Salary
- Gregory J. Divis
- Director and Chief Executive Officer
- 985.20K
- Thomas S. Mchugh
- Chief Financial Officer and Principal Accounting Officer
- 663.14K
- Richard J Kim
- Chief Commercial Officer
- 770.95K
- Scott Macke
- Vice President, Supply Chain and Operations
- --
- Geoffrey M. Glass
- Non-Executive Chairman of the Board
- 482.34K
- Peter J. Thornton
- Independent Director
- 459.84K
- Dr. Eric J. Ende, M.B.A.,M.D.
- Independent Director
- 452.34K
- Linda S. Palczuk
- Independent Director
- 452.34K
- Dr. Mark A. Mccamish, M.D.,PhD
- Independent Director
- 449.84K
- Dr. Naseem S Amin, M.D.
- Independent Director
- --
- Jerad G. Seurer
- General Counsel and Corporate Secretary
- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.